Current and Resolved Drug Shortages and Discontinuations Reported to FDA
Report a Drug Shortage |
FAQ |
Background Info |
Get Email Alerts |
Download Current Drug Shortages |
Contact Us
Start Over | Back to Previous Screen
Somatropin Injection
Status: Currently in Shortage
»Date first posted:
01/06/2023
»Therapeutic Categories: Endocrinology/Metabolism
Eli Lilly and Co. (Reverified 04/17/2024)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Humatrope, Injection, 12 mg/vial (NDC 0002-8148-01) | Available | ||
| Humatrope, Injection, 24 mg/vial (NDC 0002-8149-01) | Available |
Genentech, Inc (Revised 03/22/2024)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Nutropin Aq, Injection, 10 mg/2 mL (NDC 50242-074-01) | Limited Availability | Discontinuation of the manufacture of the drug | |
| Nutropin Aq, Injection, 5 mg/2 mL (NDC 50242-075-01) | Limited Availability | Discontinuation of the manufacture of the drug | |
| Nutropin Aq, Injection, 20 mg/2 mL (NDC 50242-076-01) | Limited Availability | Discontinuation of the manufacture of the drug |
Novo Nordisk, Inc. (Reverified 04/30/2024)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Norditropin, Injection, 5 mg/1.5 mL (NDC 0169-7704-21) | Limited Availability | Intermittent supply until end of Q2 2024 | Delay in shipping of the drug |
| Norditropin, Injection, 10 mg/1.5 mL (NDC 0169-7705-21) | Available | ||
| Norditropin, Injection, 15 mg/1.5 mL (NDC 0169-7708-21) | Available | ||
| Norditropin, Injection, 30 mg/3 mL (NDC 0169-7703-21) | Unavailable | Unavailable until end of 2024 | Delay in shipping of the drug |
Pfizer Inc. (Revised 04/18/2024)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Genotropin, Injection, 5 mg/mL, w/ preservative (NDC 0013-2626-81) | Available | ||
| Genotropin, Injection, 12 mg/mL, w/ preservative (NDC 0013-2646-81) | Available | ||
| Genotropin, Injection, 0.2 mg/vial (NDC 0013-2649-02) | Available | ||
| Genotropin, Injection, 0.4 mg/vial (NDC 0013-2650-02) | Unavailable | Next Delivery: June 2024; Estimated Recovery: late Q3 2024 | Demand increase for the drug |
| Genotropin, Injection, 0.6 mg/vial (NDC 0013-2651-02) | Available | ||
| Genotropin, Injection, 0.8 mg/vial (NDC 0013-2652-02) | Available | ||
| Genotropin, Injection, 1.0 mg/vial (NDC 0013-2653-02) | Available | ||
| Genotropin, Injection, 1.2 mg/vial (NDC 0013-2654-02) | Available | ||
| Genotropin, Injection, 1.4 mg/vial (NDC 0013-2655-02) | Available | ||
| Genotropin, Injection, 1.6 mg/vial (NDC 0013-2656-02) | Available | ||
| Genotropin, Injection, 1.8 mg/vial (NDC 0013-2657-02) | Available | ||
| Genotropin, Injection, 2.0 mg/vial (NDC 0013-2658-02) | Available |
Sandoz Inc. (Reverified 04/22/2024)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Omnitrope, Injection, 5 mg/1.5 mL (NDC 0781-3001-07) | Available | ||
| Omnitrope, Injection, 10 mg/1.5 mL (NDC 0781-3004-07) | Available |